PODD Earnings Date: Nov 4, 2026 (Estimated) — Insulet Corp.
NASDAQ · Healthcare · Medical Devices
Updated
When is PODD's next earnings date?
Insulet Corp. (PODD) is expected to report earnings on Wednesday, November 4, 2026; the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $1.59 on revenue of $832.6M.
How did PODD do in its last earnings report?
In its most recent report on Aug 5, 2026 (Q2 2026), Insulet Corp. posted EPS of $1.66 versus the $1.47 estimate, a beat of 15.3%. Revenue was $801.7M against a $787.4M estimate. The stock's 1-day post-earnings move was -20.1%.
How much does PODD stock move after earnings?
PODD beat EPS estimates in 8 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 8.1% (up or down) in the day after earnings.
About Insulet Corp.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-05 | Q2 2026 | 1.47 | 1.66 | +15.28% | $801.7M | ✅ Beat | -20.12% | -13.26% | -11.20% |
| 2026-05-06 | Q1 2026 | 1.18 | 1.42 | +20.34% | $761.7M | ✅ Beat | -9.70% | -5.48% | -12.61% |
| 2026-02-18 | Q4 2025 | 1.47 | 1.55 | +5.44% | $783.8M | ✅ Beat | +4.76% | -0.44% | -6.52% |
| 2025-11-06 | Q3 2025 | 1.14 | 1.24 | +8.77% | $706.3M | ✅ Beat | +2.85% | +7.12% | -3.16% |
| 2025-08-07 | Q2 2025 | 0.93 | 1.17 | +25.81% | $649.1M | ✅ Beat | +9.47% | +11.32% | +25.65% |
| 2025-02-20 | Q4 2024 | 1.02 | 1.15 | +12.75% | $597.5M | ✅ Beat | -1.90% | -7.35% | -6.93% |
| 2024-11-07 | Q3 2024 | 0.76 | 0.90 | +18.42% | $543.9M | ✅ Beat | +9.40% | +6.60% | +8.22% |
| 2024-02-22 | Q4 2023 | 0.66 | 1.40 | +112.12% | $509.8M | ✅ Beat | -6.56% | -16.81% | -16.65% |
Showing last 8 quarters.